본문 바로가기
KERD
논문KCI 등재

Health-related Quality of Life Instrument With 8 Items for Use in Patients With Type 2 Diabetes Mellitus: A Validation Study in Korea

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objectives: This study assessed the validity and reliability of the Health-related Quality of Life Instrument with 8 Items (HINT-8) in patients with diabetes. HINT-8 is a newly-developed, generic health-related quality of life (HRQoL) instrument. Methods: Three HRQoL instruments—HINT-8, EuroQoL 5-Dimension 5-Level (EQ-5D-5L), and Short Form Health Survey version 2.0 (SF-36v2)—were provided to 300 patients with diabetes visiting a tertiary hospital for follow-up visits in Korea. The HRQoL scores obtained using the HINT-8 were evaluated for subgroups with known differences based on demographics and diabetes-related characteristics (known-group validity). The mean scores of the instruments were compared between groups segmented by their responses to the HINT-8 (discriminatory ability). Correlation coefficients of the HINT-8 with other instruments were calculated (convergent and divergent validity). The Cohen kappa and intra-class correlation coefficient (ICC) were also evaluated (test-retest reliability). Results: The average HINT-8 indexes were lower among women, older, and less-educated subjects. Subjects who did not list any problems on the HINT-8 had significantly higher HRQoL scores than those who did. The correlation coefficients of the HINT-8 with the EQ-5D-5L index and EuroQoL visual analogue scale were 0.715 (p<0.001) and 0.517 (p<0.001), respectively. The correlation coefficients between the HINT-8 index and the scores of 8 domains of the SF-36v2 ranged from 0.478 (p<0.001) to 0.669 (p<0.001). The Cohen kappa values for the HINT-8 ranged from 0.268 to 0.601, and the ICC of the HINT-8 index was 0.800 (95% confidence interval [CI], 0.720 to 0.860).

Abstract

Objectives: This study assessed the validity and reliability of the Health-related Quality of Life Instrument with 8 Items (HINT-8) in patients with diabetes. HINT-8 is a newly-developed, generic health-related quality of life (HRQoL) instrument. Methods: Three HRQoL instruments—HINT-8, EuroQoL 5-Dimension 5-Level (EQ-5D-5L), and Short Form Health Survey version 2.0 (SF-36v2)—were provided to 300 patients with diabetes visiting a tertiary hospital for follow-up visits in Korea. The HRQoL scores obtained using the HINT-8 were evaluated for subgroups with known differences based on demographics and diabetes-related characteristics (known-group validity). The mean scores of the instruments were compared between groups segmented by their responses to the HINT-8 (discriminatory ability). Correlation coefficients of the HINT-8 with other instruments were calculated (convergent and divergent validity). The Cohen kappa and intra-class correlation coefficient (ICC) were also evaluated (test-retest reliability). Results: The average HINT-8 indexes were lower among women, older, and less-educated subjects. Subjects who did not list any problems on the HINT-8 had significantly higher HRQoL scores than those who did. The correlation coefficients of the HINT-8 with the EQ-5D-5L index and EuroQoL visual analogue scale were 0.715 (p<0.001) and 0.517 (p<0.001), respectively. The correlation coefficients between the HINT-8 index and the scores of 8 domains of the SF-36v2 ranged from 0.478 (p<0.001) to 0.669 (p<0.001). The Cohen kappa values for the HINT-8 ranged from 0.268 to 0.601, and the ICC of the HINT-8 index was 0.800 (95% confidence interval [CI], 0.720 to 0.860).

참고문헌 (40)

  1. Cho NH, "Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045", Diabetes Res Clin Pract, 138, pp.271~281 (2018)
  2. Harding JL, "Global trends in diabetes complications : a review of current evidence", Diabetologia, 62(1), pp.3~16 (2019)
  3. Forssas E, "Multiple complications among people with diabetes from Finland : an 18-year follow-up in 1994-2011", BMJ Open Diabetes Res Care, 4(1), pp.e000254~ (2016)
  4. 원종철, "Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status", Diabetes and Metabolism Journal, 42(5), pp.415~424 (2018), 대한당뇨병학회[DOI]
  5. Lee JW, "Trends in diabetes prevalence among Korean adults based on Korean National Health and Nutrition Examination Surveys III-VI", Diabetes Res Clin Pract, 138, pp.57~65 (2018)
  6. 김경진, "Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013", Diabetes and Metabolism Journal, 42(5), pp.394~401 (2018), 대한당뇨병학회[DOI]
  7. Karimi M, "Health, health-related quality of life, and quality of life: what is the difference?", Pharmacoeconomics, 34(7), pp.645~649 (2016)
  8. Megari K, "Quality of life in chronic disease patients", Health Psychol Res, 1(3), pp.e27~ (2013)
  9. Health Insurance Review and Assessment Service, "Guidelines for economic evaluation of pharmaceuticals. 2nd ed", Health Insurance Review and Assessment Service, 10~ (2011)
  10. Janssen MF, "Comparing the standard EQ-5D three-level system with a five-level version", Value Health, 11(2), pp.275~284 (2008)
  11. 이우제, "Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes", Journal of Korean Medical Science, 27(3), pp.255~260 (2012), 대한의학회
  12. Kim SH, "Validity and reliability of EQ-5D-3L for breast cancer patients in Korea", Health Qual Life Outcomes, 13, pp.203~ (2015)
  13. Kim SH, "The EQ-5D-5L valuation study in Korea", Qual Life Res, 25(7), pp.1845~1852 (2016)
  14. Kim SH, "Validity and reliability of the EQ-5D for cancer patients in Korea", Support Care Cancer, 20(12), pp.3155~3160 (2012)
  15. Kim SH, "Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea", Qual Life Res, 21(6), pp.1065~1073 (2012)
  16. Kim SK, "Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke", Health Qual Life Outcomes, 13, pp.32~ (2015)
  17. Kim TH, "Psychometric properties of the EQ-5D-5L in the general population of South Korea", Qual Life Res, 22(8), pp.2245~2253 (2013)
  18. Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states", Value Health, 12(8), pp.1187~1193 (2009)
  19. Ock M, "Measuring health related quality of life using EQ-5D in South Korea", J Health Tech Assess, 1(1), pp.103~111 (2013)
  20. Seon Ha Kim, "Psychometric Properties of the Korean Short Form-36 Health Survey Version 2 for Assessing the General Population", Asian Nursing Research, 7(2), pp.61~66 (2013), 한국간호과학회
  21. Development of the measurement tool for health related quality of life in the Korea National Health and Nutrition Examination Survey, "Jo MW", Korea Centers for Disease Control and Prevention, 97~ (2014)
  22. Lee HJ, "Development and psychometric evaluation of measurement instrument for Korean health-related quality of life", Public Health Wkly Rep, 9(24), pp.447~454 (2016)
  23. 이은현, "국내 연구에서 당뇨병 환자 건강관련 삶의 질 측정에 관한 모니터링", Journal of Korean Academy of Nursing, 41(4), pp.558~567 (2011), 한국간호과학회
  24. El Achhab Y, "Disease-specific health-related quality of life instruments among adults diabetic : a systematic review", Diabetes Res Clin Pract, 80(2), pp.171~184 (2008)
  25. Hu J, "Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China", Diabetes Res Clin Pract, 88(3), pp.273~281 (2010)
  26. Valuation of Korean health-related quality of life instrument with 8 items (HINT-8), "Jo MW", Korean Centers for Disease Control and Prevention, 28~ (2017)
  27. van Reenen M, "EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument", EuroQol Research Foundation, 9~ (2015)
  28. Maruish ME, "User’s manual for the SF-36v2 health survey", Quality Metric Incorporated, 198~ (2011)
  29. Brazier JE, "The estimation of a preference-based measure of health from the SF-12", Med Care, 42(9), pp.851~859 (2004)
  30. Brazier J, "The estimation of a preference-based measure of health from the SF-36", J Health Econ, 21(2), pp.271~292 (2002)
  31. Fayers PM, "Assessing quality of life in clinical trials: methods and practice", pp.421~ (2005), Oxford University Press
  32. Viera AJ, "Understanding interobserver agreement : the kappa statistic", Fam Med, 37(5), pp.360~363 (2005)
  33. Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research", J Chiropr Med, 15(2), pp.155~163 (2016)
  34. Streiner DL, "Health measurement scales: a practical guide to their development and use", pp.177~ (2014), Oxford University Press
  35. Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33(1), pp.159~174 (1977)
  36. Janssen MF, "Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups : a multi-country study", Qual Life Res, 22(7), pp.1717~1727 (2013)
  37. Janssen MF, "Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries", Pharmacoeconomics, 36(6), pp.675~697 (2018)
  38. Mulhern B, "The construct validity and responsiveness of the EQ-5D, SF-6D and diabetes health profile-18 in type 2 diabetes", Health Qual Life Outcomes, 12, pp.42~ (2014)
  39. Kiadaliri AA, "Does the choice of EQ-5D tariffmatter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients", Health Qual Life Outcomes, 13, pp.145~ (2015)
  40. Koh D, "Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes", PLoS One, 11(11), pp.e0165555~ (2016)

관련 논문AI추천

이 간행물의 다른 논문 (12건)